Professor
Hanns Möhler, M.D. 
Present Positions (since 1988): Head, Institute of Pharmacology and Toxicology, University of Zürich, and Head, Department of Applied Biosciences, Eidgenössische Technische Hochschule (ETH), Zürich
Working areas: Pharmacology, Neuropharmacology, Neurosciences, Molecular Medicine, Behavioural Sciences
Curriculum
vitae:
Born 1940 in Germany
Study of Chemistry and Biochemistry at the Universities of Bonn, Tübingen
and Freiburg
PhD of Biochemistry 1968 (Freiburg)
Guest Scientist/Professor at Michigan State University (67-68), University
of Freiburg (68-71), Medical Research Council London (72-73 - Senior
Research Scientist), Research Department Hoffmann-La Roche Basel (73-88
- Department Director and Vize-Director)
Member of several Swiss and International Research Review Committees
Recipient of numerous academic Honours and Awards
Most
important scientific achievements:
Discovery of the benzodiazepin receptor and of the GABA receptor heterogeneity
Elucidation of the mechanism of action of the benzodiazepins
Key role in the discovery of the benzodiazepin antagonist flumenazil
Discovery of the role of deficient GABA receptors as a genetic factor
of anxiety reactions
Description of neuronal circuits for the regulation of emotions
Establishment of a single point mutation technique for drug modelling,
i.e. for the development of specific ligands for GABA receptor subtypes
